
    
      Study to evaluate the pharmacokinetic parameters, relative bioavailability and bioequivalence
      of drugs containing darunavir - GP30101 and PrezistaÂ® in healthy volunteers after single
      orally administered dose, under fed conditions A comparative analysis of adverse events
      aditionally conducted in this study.
    
  